Glaxosmi. Pharma

Glaxosmithkline Pharmaceuticals Ltd Quarterly Results

NSEBSE

₹2,802.7

(-3.89%)

Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Dec-2024	Sept-2024	Jun-2024	Mar-2024	Dec-2023
Gross Sales	949.42	1,010.77	814.65	929.8	805.26
Excise Duty	0	0	0	0	0
Net Sales	949.42	1,010.77	814.65	929.8	805.26
Other Operating Income	0	0	0	0	0
Other Income	35.07	39.23	35.64	32.23	28.11
Total Income	984.49	1,050	850.29	962.03	833.37
Total Expenditure	657.5	689.06	584.11	672.54	750.51
PBIDT	326.99	360.94	266.18	289.49	82.86
Interest	0.09	0.27	0.37	0.77	0.32
PBDT	326.9	360.67	265.81	288.72	82.54
Depreciation	18.8	16.86	16.41	18.1	17.11
Minority Interest Before NP	0	0	0	0	0
Tax	73.49	98.76	63.56	61.67	31.41
Deferred Tax	4.73	-7.45	3.51	14.47	-11.7
Reported Profit After Tax	229.88	252.5	182.33	194.48	45.72
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	229.88	252.5	182.33	194.48	45.72
Extra-ordinary Items	0	3.34	0	1.72	-131.9
Adjusted Profit After Extra-ordinary item	229.88	249.16	182.33	192.76	177.62
EPS (Unit Curr.)	13.57	14.67	10.76	11.37	9.89
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	240	120	0	0	0
Equity	169.41	169.41	169.41	169.41	169.41
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	34.44	35.7	32.67	31.13	10.28
PBDTM(%)	34.43	35.68	32.62	31.05	10.25
PATM(%)	24.21	24.98	22.38	20.91	5.67